The Anti-NMDA Receptor Encephalitis Foundation Newsletter

Call for Society Prizes | 2021 Congress SOCIETY PRIZES CNSF members have the opportunity to win valuable society prizes by submitting ‘Abstracts’ to the Congress as well as an ‘Expanded Abstracts’ to the society prize competitions. There are multiple first place prizes available to Junior Members or an Active Member within two years of receiving their certificate. Each valued at approximately $2500. Winners have the privilege of presenting their work at the Grand Plenary, alongside our Distinguished Guest Lecturers, during the Congress. Prize winners’ will be announced in the Neuro|News newsletter, in the Canadian Journal of Neurological Sciences and on the CNSF website. $500 second place prizes and additional subsidiary prizes may be awarded. Rules governing all Society Prize Submissions Authors are invited to submit an expanded abstract, on or before April 30, 2021 Contestants must be a member in good standing with any one of the five Societies of the CNSF; a Junior member or an Active member within two years of receiving their certificate. (Become a Member | CNSF) The same person may submit on different topics for the same prize The same expanded abstract may not be submitted to more than one Society Submissions must be provided in PDF format Those submitting an expanded abstract for a Society Prize must also submit their basic abstract to the CNSF Congress, on the official online abstract submission site. The Congress Abstract submission process is independent from the Society Prize submission process. Submission Details Prize submissions accepted by email ONLY Clearly indicate name of Society Prize you are submitting for Submissions must be submitted as three separate PDF files label: last name_ ‘Letter’ from their program chair ‘Biography’ ‘Expanded Abstract’ (include abstract number) CNSF will send a receipt of confirmation within 5 business days. If you do not receive a receipt of confirmation after 6 business days please contact the CNSF at nicole-rozak@cnsf.org The Canadian Neurological Society (CNS) Francis McNaughton Memorial Prize André Barbeau Memorial Prize Anti-NMDA Receptor Encephalitis Foundation Prize The Canadian Neurosurgical Society (CNSS) K.G. McKenzie Memorial Prize for Basic Neuroscience Research Prize K.G. McKenzie Memorial Prize for Clinical Neuroscience Research Prize The Canadian Society of Clinical Neurophysiologists (CSCN) Herbert Jasper Prize The Canadian Association of Child Neurology (CACN) President’s Prize The Canadian Society of Neuroradiology (CSNR) CSNR Society Prize

 




Background: Anti-N-methyl-D-aspartate receptor (NMDAR) immunoglobulin G antibodies which exist on myelin sheaths, composed of oligodendrocytes, especially target GluN1 subunits and are highly characteristic of anti-NMDAR encephalitis which is a newly recognized autoimmune encephalitis (AE) ch …

 




Anti-N-methyl-D-aspartate receptor encephalitis is a clinical condition characterized by acute behavioral and mood changes, abnormal movements, autonomic instability, seizures, and encephalopathy.We describe a 7-year-old boy diagnosed with autoimmune encephalitis due to NMDAR antibody in associatio…

 




A woman from Lincoln who was sectioned after being wrongly diagnosed as mentally ill is raising awareness of what happened to her.

 




Encephalitis with antibodies against N-methyl-D-aspartate receptor (NMDA-R) is classified as an autoimmune disorder with psychotic symptoms, which are frequently dominant. However, it remains unclear how frequently NMDA-R antibodies lead to a condition …

 




Autoimmune encephalitis (AE) is an increasingly recognized inflammatory disorder of the central nervous system and is most often characterized by anti……

 




Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune synaptic encephalitis likely mediated by neuronal surface antibody. Clinically, it is characterized by a variety of neurological and psychiatric symptoms, predominantly affecting young women.

 




Anti-IgLON5 disease is a progressive neurological disorder associated with autoantibodies against a neuronal cell adhesion molecule, IgLON5. In human postmortem brain tissue, the neurodegeneration and accumulation of hyperphosphorylated tau (p-tau) are found.

 




COVID-19 patients are at increased risk for developing new or recurrent psychosis.(1) Viral infections—including SARS-CoV-2 (2-4)—can cause psychosis in the context of autoimmune encephalitis.(5) However, some individuals with para-infectious psychosis do not meet criteria for autoimmune…

 




Autoimmune encephalitis, inflammatory diseases of the brain, present with a wide range of neurological and psychiatric symptoms, most of them common in autism…

 




Your donations enable our work. Please consider contributing today. https://www.antinmdafoundation.org/donate/